Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Intra-Cellular Therapies EPS - Earnings per Share 2013-2019 | ITCI

Intra-Cellular Therapies eps - earnings per share from 2013 to 2019. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  
Intra-Cellular Therapies Annual EPS
2018 $-2.84
2017 $-2.12
2016 $-2.69
2015 $-2.91
2014 $-1.07
2013 $-1.56
2012 $-2.96
Intra-Cellular Therapies Quarterly EPS
Q3 2019 $-0.63
Q2 2019 $-0.68
Q1 2019 $-0.63
Q4 2018 $-0.75
Q3 2018 $-0.76
Q2 2018 $-0.68
Q1 2018 $-0.65
Q4 2017 $-0.56
Q3 2017 $-0.53
Q2 2017 $-0.41
Q1 2017 $-0.62
Q4 2016 $-0.64
Q3 2016 $-0.70
Q2 2016 $-0.71
Q1 2016 $-0.64
Q4 2015 $-0.67
Q3 2015 $-0.91
Q2 2015 $-0.61
Q1 2015 $-0.72
Q4 2014 $-0.53
Q3 2014 $-0.22
Q2 2014 $-0.15
Q1 2014 $-0.17
Q4 2013 $-0.33
Q3 2013 $-0.28
Q2 2013 $-0.56
Q1 2013 $-0.39
Q4 2012 $0.00
Q3 2012 $-0.40
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.455B $0.000B
Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.489B 16.53
CSL (CSLLY) Australia $94.378B 0.00
Gilead Sciences (GILD) United States $79.679B 9.87
Vertex Pharmaceuticals (VRTX) United States $60.644B 61.90
Biogen (BIIB) United States $51.516B 8.84
Illumina (ILMN) United States $47.734B 52.37
Regeneron Pharmaceuticals (REGN) United States $42.374B 18.56
Alexion Pharmaceuticals (ALXN) United States $25.066B 12.38
Seattle Genetics (SGEN) United States $18.681B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.631B 0.00
Incyte (INCY) United States $17.339B 40.25
BioMarin Pharmaceutical (BMRN) United States $15.856B 0.00
Genmab (GNMSF) Denmark $13.895B 61.37
Alnylam Pharmaceuticals (ALNY) United States $13.247B 0.00
Galapagos (GLPG) Belgium $12.482B 32.16
Exact Sciences (EXAS) United States $11.433B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.238B 53.94
BeiGene (BGNE) Cayman Islands $10.404B 0.00
Sarepta Therapeutics (SRPT) United States $9.534B 0.00
Bio-Techne Corp (TECH) United States $8.408B 56.28
QIAGEN (QGEN) Netherlands $8.064B 26.29
Guardant Health (GH) United States $7.944B 0.00
BioNTech SE (BNTX) Germany $7.507B 0.00
Horizon Therapeutics Public (HZNP) Ireland $7.192B 18.29
Amarin (AMRN) Ireland $7.112B 0.00
Moderna (MRNA) United States $6.872B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.689B 0.00
Reata Pharmaceuticals (RETA) United States $6.400B 0.00
Exelixis (EXEL) United States $6.022B 16.94
ARGENX SE-ADR (ARGX) Netherlands $5.884B 0.00
Ascendis Pharma (ASND) Denmark $5.862B 0.00
Bluebird Bio (BLUE) United States $5.425B 0.00
Repligen (RGEN) United States $5.243B 95.01
China Biologic Products (CBPO) China $4.558B 25.68
MorphoSys AG (MOR) Germany $4.166B 0.00
Blueprint Medicines (BPMC) United States $3.990B 0.00
Mirati Therapeutics (MRTX) United States $3.827B 0.00
Immunomedics (IMMU) United States $3.675B 0.00
Adaptive Biotechnologies (ADPT) United States $3.508B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.473B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.464B 0.00
MyoKardia (MYOK) United States $3.409B 0.00
NeoGenomics (NEO) United States $3.346B 178.06
CRISPR Therapeutics AG (CRSP) Switzerland $3.220B 0.00
Zai Lab (ZLAB) China $3.085B 0.00
Alkermes (ALKS) Ireland $3.031B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.030B 0.00
Acceleron Pharma (XLRN) United States $2.980B 0.00
UniQure (QURE) Netherlands $2.946B 0.00
Genmab (GMAB) Denmark $2.929B 6.03
Halozyme Therapeutics (HALO) United States $2.926B 0.00
Emergent Biosolutions (EBS) United States $2.868B 28.49
Amicus Therapeutics (FOLD) United States $2.653B 0.00
Epizyme (EPZM) United States $2.434B 0.00
Arena Pharmaceuticals (ARNA) United States $2.339B 5.44
RA PHARMCTL INC (RARX) United States $2.214B 0.00
Denali Therapeutics (DNLI) United States $2.147B 0.00
Myriad Genetics (MYGN) United States $2.136B 31.56
Principia Biopharma (PRNB) United States $2.070B 0.00
Fate Therapeutics (FATE) United States $1.939B 0.00
Zymeworks (ZYME) Canada $1.935B 0.00
Insmed (INSM) United States $1.917B 0.00
REGENXBIO (RGNX) United States $1.774B 0.00
Arvinas (ARVN) United States $1.718B 0.00
Akcea Therapeutics (AKCA) United States $1.601B 0.00
Ligand Pharmaceuticals (LGND) United States $1.588B 30.54
Editas Medicine (EDIT) United States $1.572B 0.00
Alector (ALEC) United States $1.474B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.461B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.390B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.376B 0.00
Coherus BioSciences (CHRS) United States $1.344B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.184B 0.00
DBV Technologies S.A (DBVT) France $1.157B 0.00
Zealand Pharma (ZEAL) Denmark $1.156B 0.00
Codexis (CDXS) United States $1.060B 0.00
Revance Therapeutics (RVNC) United States $1.013B 0.00
Sangamo Therapeutics (SGMO) United States $0.970B 0.00
PHARMA MAR SA (PHMMF) Spain $0.965B 0.00
Pharming Group (PHGUF) Netherlands $0.939B 0.00
Mesoblast (MESO) Australia $0.936B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.902B 0.00
Heska (HSKA) United States $0.845B 215.86
ZIOPHARM Oncology Inc (ZIOP) United States $0.840B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.806B 6.78
Vericel (VCEL) United States $0.781B 291.17
Cellectis S.A (CLLS) France $0.774B 0.00
GENFIT S.A (GNFT) France $0.773B 0.00
Adverum Biotechnologies (ADVM) United States $0.757B 0.00
Twist Bioscience (TWST) United States $0.756B 0.00
ANI Pharmaceuticals (ANIP) United States $0.741B 12.63
NantKwest (NK) United States $0.723B 0.00
Cytokineticsorporated (CYTK) United States $0.717B 0.00
Intellia Therapeutics (NTLA) United States $0.715B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.713B 0.00
UROGEN PHARMA (URGN) United States $0.707B 0.00
Sorrento Therapeutics (SRNE) United States $0.701B 0.00
Retrophin (RTRX) United States $0.695B 0.00
Cara Therapeutics (CARA) United States $0.693B 0.00
Anika Therapeutics (ANIK) United States $0.648B 21.03
AC Immune SA (ACIU) Switzerland $0.622B 14.38
Kadmon Holdings (KDMN) United States $0.589B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.578B 0.00
Prothena (PRTA) Ireland $0.569B 0.00
Precision BioSciences (DTIL) United States $0.542B 0.00
Agenus (AGEN) United States $0.541B 0.00
Clovis Oncology (CLVS) United States $0.540B 0.00
BioDelivery Sciences (BDSI) United States $0.522B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.513B 0.00
Dynavax Technologies (DVAX) United States $0.506B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.504B 0.00
Bellus Health (BLU) Canada $0.486B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.473B 0.00
Arcus Biosciences (RCUS) United States $0.469B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.450B 0.00
AnaptysBio (ANAB) United States $0.431B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.429B 2.97
Gritstone Oncology (GRTS) United States $0.402B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.401B 0.00
Merus (MRUS) Netherlands $0.397B 0.00
Mersana Therapeutics (MRSN) United States $0.385B 0.00
Kindred Biosciences (KIN) United States $0.385B 0.00
Puma Biotechnology (PBYI) United States $0.379B 0.00
PDL BioPharma (PDLI) United States $0.372B 9.31
Avid Bioservices (CDMO) United States $0.368B 0.00
Syros Pharmaceuticals (SYRS) United States $0.361B 0.00
Cue Biopharma (CUE) United States $0.354B 0.00
Stemline Therapeutics (STML) United States $0.352B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
CytomX Therapeutics (CTMX) United States $0.339B 0.00
Cellular Biomedicine (CBMG) United States $0.337B 0.00
Inovio Pharmaceuticals (INO) United States $0.329B 0.00
Albireo Pharma (ALBO) United States $0.317B 0.00
Compugen (CGEN) Israel $0.314B 0.00
MannKind (MNKD) United States $0.312B 0.00
Starpharma Holdings (SPHRY) Australia $0.303B 0.00
OSMOTICA PHARM (OSMT) United States $0.302B 0.00
VBI Vaccines (VBIV) United States $0.291B 0.00
IVERIC Bio (ISEE) United States $0.282B 0.00
Geron (GERN) United States $0.282B 0.00
Sutro Biopharma (STRO) United States $0.276B 0.00
WAVE Life Sciences (WVE) Singapore $0.270B 0.00
ADMA Biologics Inc (ADMA) United States $0.265B 0.00
Kamada (KMDA) Israel $0.263B 7.67
ChromaDex (CDXC) United States $0.260B 0.00
Prometic Life Sciences (LMNL) Canada $0.257B 0.00
Biofrontera AG (BFRA) Germany $0.254B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.245B 0.00
Seres Therapeutics (MCRB) United States $0.240B 0.00
Affimed (AFMD) Germany $0.230B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.230B 0.00
Cerecor (CERC) United States $0.222B 0.00
Theratechnologies (THTX) Canada $0.218B 0.00
XOMA (XOMA) United States $0.215B 0.00
Exicure (XCUR) United States $0.214B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.214B 0.00
Athersys (ATHX) United States $0.199B 0.00
Protagonist Therapeutics (PTGX) United States $0.199B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.198B 0.00
Five Prime Therapeutics (FPRX) United States $0.193B 0.00
Arbutus Biopharma (ABUS) Canada $0.191B 0.00
Novavax (NVAX) United States $0.184B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.184B 0.00
ARAVIVE, INC (ARAV) United States $0.184B 0.00
Fortress Biotech (FBIO) United States $0.183B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.182B 0.00
Alcobra (ARCT) United States $0.180B 0.00
Windtree Therapeutics (WINT) United States $0.172B 0.00
TELA Bio (TELA) United States $0.170B 0.00
Spero Therapeutics (SPRO) United States $0.170B 0.00
PHASEBIO PHARMA (PHAS) United States $0.168B 0.00
Menlo Therapeutics (MNLO) United States $0.163B 0.00
Selecta Biosciences (SELB) United States $0.160B 0.00
Dyadic (DYAI) United States $0.159B 0.00
Aptinyx (APTX) United States $0.154B 0.00
Applied Genetic Technologies (AGTC) United States $0.149B 0.00
Strongbridge Biopharma (SBBP) United States $0.149B 3.97
Verastem (VSTM) United States $0.141B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.130B 0.00
Abeona Therapeutics (ABEO) United States $0.130B 0.00
Arsanis (XFOR) United States $0.129B 0.00
VTv Therapeutics (VTVT) United States $0.128B 0.00
Clearside Biomedical (CLSD) United States $0.126B 0.00
Enzo Biochem (ENZ) United States $0.125B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.121B 0.00
Liquidia Technologies (LQDA) United States $0.120B 0.00
Celyad SA (CYAD) Belgium $0.118B 0.00
Aduro Biotech (ADRO) United States $0.113B 0.00
Antibe Therapeutics (ATBPF) Canada $0.112B 0.00
Happiness Biotech Group (HAPP) China $0.110B 0.00
OvaScience (MLND) United States $0.106B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.102B 0.00
SESEN BIO, INC (SESN) United States $0.102B 0.00
Proteostasis Therapeutics (PTI) United States $0.100B 0.00
Acorda Therapeutics (ACOR) United States $0.099B 0.00
Synlogic (SYBX) United States $0.096B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Emmaus Life Sciences (EMMA) United States $0.090B 0.00
Catalyst Biosciences (CBIO) United States $0.089B 0.00
Orgenesis (ORGS) United States $0.087B 5.63
Adocia (ADOCY) France $0.086B 0.00
Prima BioMed (IMMP) Australia $0.084B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.083B 0.00
Trevena (TRVN) United States $0.081B 0.00
NewLink Genetics (NLNK) United States $0.076B 0.00
Vaccinex (VCNX) United States $0.076B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.072B 0.00
Checkpoint Therapeutics (CKPT) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Pluristem Therapeutics (PSTI) Israel $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.062B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.062B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Curis (CRIS) United States $0.057B 0.00
DiaMedica Therapeutics (DMAC) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
AquaBounty Technologies (AQB) United States $0.049B 0.00
CollPlant Holdings (CLGN) Israel $0.044B 0.00
Evogene (EVGN) Israel $0.044B 0.00
Soligenix (SNGX) United States $0.043B 0.00
Celldex Therapeutics (CLDX) United States $0.040B 0.00
Celsion (CLSN) United States $0.037B 0.00
BioCardia (BCDA) United States $0.035B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
Entera Bio (ENTX) Israel $0.033B 0.00
Bionano Genomics (BNGO) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.031B 0.00
Aptevo Therapeutics (APVO) United States $0.031B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
Unum Therapeutics (UMRX) United States $0.029B 0.00
VIVUS (VVUS) United States $0.029B 0.00
Novogen (KZIA) Australia $0.029B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
Advaxis (ADXS) United States $0.021B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.014B 0.00
Cesca Therapeutics (THMO) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00